
PharmaMar
Biopharmaceutical company specializing in the discovery, development, and commercialization of marine-derived drugs for cancer and other serious diseases.
Market cap
$1.5b
Enterprise value
$1.4b
Share price
€79.50 PHM.MC
Authorizing premium user...